Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T J Mühlebach

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
European Journal of Pediatrics|June 1, 1991
Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous diseaseT J Mühlebach, H J Feickert, K Welte, et al.
Clinical and Experimental Immunology|May 1, 1992
Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteinsT J Mühlebach, J Gabay, C F Nathan, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
European Journal of Pediatrics|June 1, 1991
Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous diseaseT J Mühlebach, H J Feickert, K Welte, et al.
Clinical and Experimental Immunology|May 1, 1992
Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteinsT J Mühlebach, J Gabay, C F Nathan, et al.
Pageof 1